1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Core One Labs Inc.
  6. News
  7. Summary
    COOL   CA21872J3073

CORE ONE LABS INC.

(COOL)
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  05/19 03:30:33 pm EDT
0.5600 CAD   -20.00%
04/25Core One Labs Inc. Announces Delay in Filing Audited Consolidated Financial Statements
CI
04/06Core One Labs' Upgrades to OTCQB Venture Market
AQ
04/02Core One Labs' Akome Receives Positive Results from Bioassay Studies
AQ
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lifestyle Delivery Systems Inc. (CSE:LDS, OTCQB:LDSYF, Frankfurt:LD6, WKN:A14XHT) acquired membership interests in NHMC Inc. and CSPA Group Inc. from Debora and Jerry Davis for $3.4 million.

02/23/2018 EDT

Lifestyle Delivery Systems Inc. (CSE:LDS, OTCQB:LDSYF, Frankfurt:LD6, WKN:A14XHT) ("LDS") acquired membership interests in NHMC Inc. and CSPA Group Inc. from Debora B. Davis and Jerry R. Davis for $3.4 million on February 21, 2018. LDS paid $1,250,000 in cash in addition to $150,000 paid in the September 2017 fiscal quarter towards the proposed acquisition and issued 3 million shares of its common stock as consideration for the purchase. The shares issued will be held in escrow at closing. An additional 3 million common shares that had been previously issued and placed into escrow in connection with the proposed acquisition will be surrendered for cancellation. In addition, LDS agreed to pay a total of $120,000 less standard payroll deductions and withholding allowances to the sellers on account of accrued but unpaid salaries payable to the sellers by NHMC and CSPA. The acquisition follows exercise of an option by LDS to acquire the membership interest. Buckner, Robinson & Mirkovich served as the escrow agent in connection with the deal. Lifestyle Delivery Systems Inc. (CSE:LDS, OTCQB:LDSYF, Frankfurt:LD6, WKN:A14XHT) completed the acquisition of membership interests in NHMC Inc. and CSPA Group Inc. from Debora and Jerry Davis on February 21, 2018.


© S&P Capital IQ 2018
All news about CORE ONE LABS INC.
04/25Core One Labs Inc. Announces Delay in Filing Audited Consolidated Financial Statements
CI
04/06Core One Labs' Upgrades to OTCQB Venture Market
AQ
04/02Core One Labs' Akome Receives Positive Results from Bioassay Studies
AQ
03/21Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities
MT
03/19Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities
AQ
03/15Core One's Vocan Biotechnologies and Awakened Biosciences Collaborate to Advance Vocan'..
MT
03/15Core One's Vocan Biotechnologies and Awakened Biosciences Collaborate to Advance Vocan'..
AQ
03/14Core One Labs up 5% as Proceeds with Next Steps to Produce Psilocybin
MT
03/12CORE ONE LABS PROCEEDS WITH NEXT MIL : To Produce Psilocybin
AQ
03/04Core One Labs' ' Akome Biotech Initiates Neurogenesis Stimulation and Modeling Studies
MT
More news
Financials
Sales 2020 - - -
Net income 2020 -54,6 M -42,5 M -42,5 M
Net cash 2020 1,47 M 1,14 M 1,14 M
P/E ratio 2020 -0,69x
Yield 2020 -
Capitalization 20,1 M 15,7 M 15,7 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees -
Free-Float 99,0%
Chart CORE ONE LABS INC.
Duration : Period :
Core One Labs Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Joel Shacker Chief Executive Officer & Director
Geoffrey Balderson Chief Financial Officer & Secretary
Robert E. W. Hancock Executive Chairman
John David Sanderson Director & Chief Science Officer
Santiago Ferro Chief Medical Officer